Supira Medical (Series E)
Funding Details
- Awarder
- Inbox
- Date Award
- May 17, 2025
- Vertical
- Cardiovascular
- Funding URL
- View Funding Page
- Funding Amount:
- $120,000,000
Company Info
- Traction
- Completed enrollment for the U.S. SUPPORT I Early Feasibility Study (EFS) evaluating its pVAD.
- Company Description
- Supira Medical is a clinical-stage company developing a percutaneous ventricular assist device (pVAD) aimed at treating high-risk percutaneous coronary intervention (HRPCI) and cardiogenic shock (CS). The device features a high-flow, low-profile catheter pump with real-time monitoring to minimize vascular complications.
- Market
- Medical Devices
- Location
- Los Gatos, California, USA
- Coinvestors
- Novo Holdings, Qatar Investment Authority, Cormorant Asset Management, The Capital Partnership, 415 Capital, AMED Ventures, PA MedTech VC fund, Unorthodox Ventures